Risk of Recovering Investments in New Product Development
First written in FY2016. 9 of 11 entries say "Restated". Latest entry: FY2022-Q3.
The whole theme swung hardest in 2019: 6 of 26 companies on the "Worse" side.
32 other companies' latest entry also says "Restated".
- FY2022-Q3RestatedAnnual report
「There were no material changes to the business and other risks described in the securities report for the previous fiscal year during the cumulative third quarter of the current fiscal year.」
The company states that there have been no material changes to the risk of failing to recoup investment in new product development. - FY2022-Q2RestatedAnnual report
「The Group considers its analysis of business and other risks disclosed in the annual securities report for the previous fiscal year to remain valid during the second quarter of the current consolidated cumulative period. There were no material changes to the business and other risks described in the annual securities report for the previous fiscal year during the second quarter of the current consolidated cumulative period.」
The company states that there have been no material changes to the risk of failing to recoup investment in new product development. - FY2021-Q1RestatedAnnual report
「There were no material changes to the business and other risks described in the annual securities report for the previous fiscal year during the first quarter of the current consolidated cumulative period.」
The company states that there have been no material changes to the risk of failing to recoup investment in new product development. - FY2020WorsenedAnnual report
「BIC was established to accelerate progress, but results remain insufficient」
The company identified insufficient progress after the establishment of BIC as an issue in recouping investment in new businesses and new product development. - FY2018-Q3RestatedAnnual report
「There were no material changes to the business and other risks described in the securities report for the previous fiscal year during the cumulative third quarter of the current fiscal year.」
The company states that there have been no material changes to the risk of failing to recoup investment in new product development. - FY2018-Q2RestatedAnnual report
「There were no material changes to the business and other risks described in the securities report for the previous fiscal year during the cumulative second quarter of the current fiscal year.」
The company states that there have been no material changes to the risk of failing to recoup investment in new product development. - FY2018-Q1RestatedAnnual report
「There were no material changes to the business and other risks described in the annual securities report for the previous fiscal year during the first quarter of the current consolidated cumulative period.」
The company states that there have been no material changes to the risk of failing to recoup investment in new product development. - FY2017-Q3RestatedAnnual report
「There were no material changes to the business and other risks described in the securities report for the previous fiscal year during the cumulative third quarter of the current fiscal year.」
The company states that there have been no material changes to the risk of failing to recoup investment in new product development. - FY2017-Q2RestatedAnnual report
「There were no material changes to the business and other risks described in the securities report for the previous fiscal year during the cumulative second quarter of the current fiscal year.」
The company states that there have been no material changes to the risk of failing to recoup investment in new product development. - FY2017-Q1RestatedAnnual report
「There were no material changes to the business and other risks described in the annual securities report for the previous fiscal year during the first quarter of the current consolidated cumulative period.」
The company states that there have been no material changes to the risk of failing to recoup investment in new product development. - FY2016First statedAnnual report
「The development process for new products may require considerable time and expense, and substantial capital and resources may need to be invested before the sale of new products generates revenue.」
While emphasizing research and development and technological innovation, the company identifies the development period, investment burden, and the risk that investments cannot be recouped due to competitors or substitute technologies as risks.